This topic contains a solution. Click here to go to the answer

Author Question: The primary use of entacapone in treating Parkinson's disease is to: 1. protect the liver from ... (Read 216 times)

2125004343

  • Hero Member
  • *****
  • Posts: 566
The primary use of entacapone in treating Parkinson's disease is to:
 
  1. protect the liver from damage from levodopa or carbidopa.
  2. inhibit decarboxylase enzymes, which are used to metabolize levodopa.
  3. inhibit COMT and prolong the half-life of levodopa in the blood.
  4. bind to dopamine receptors, causing their activation.

Question 2

When used alone, how should selegiline be administered?
 
  1. At 6-hour intervals to ensure maintenance of plasma levels
  2. At bedtime to decrease the drowsiness that occurs early in treatment
  3. At breakfast and lunch to decrease the potential for insomnia
  4. One hour before or 2 hours after meals to increase absorption



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

reelove4eva

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

Correct Answer: 3

Answer to Question 2

Correct Answer: 3




2125004343

  • Member
  • Posts: 566
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


tanna.moeller

  • Member
  • Posts: 328
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library